Metabolic dysfunction and obesity‐related cancer: Beyond obesity and metabolic syndrome

Abstract

Objectives: The metabolic dysfunction driven by obesity, including hyperglycemia and dyslipidemia, increases risk for developing at least 13 cancer types. The concept of “metabolic dysfunction” is often defined by meeting various combinations of criteria for metabolic syndrome. However, the lack of a unified definition of metabolic dysfunction makes it difficult to compare findings across studies. This review summarizes 129 studies that evaluated variable definitions of metabolic dysfunction in relation to obesity‐related cancer risk and mortality after a cancer diagnosis. Strategies for metabolic dysfunction management are also discussed.MethodsA comprehensive search of relevant publications in MEDLINE (PubMed) and Google Scholar with review of references was conducted.ResultsMetabolic dysfunction, defined as metabolic syndrome diagnosis or any number of metabolic syndrome criteria out of clinical range, inflammatory biomarkers, or markers of metabolic organ function, has been associated with risk for, and mortality from, colorectal, pancreatic, postmenopausal breast, and bladder cancers. Metabolic dysfunction associations with breast and colorectal cancer risk have been observed independently of BMI, with increased risk in individuals with metabolically unhealthy normal weight or overweight/obesity compared with metabolically healthy normal weight.ConclusionMetabolic dysfunction is a key risk factor for obesity‐related cancer, regardless of obesity status. Nonetheless, a harmonized definition of metabolic dysfunction will further clarify the magnitude of the relationship across cancer types, enable better comparisons across studies, and further guide criteria for obesity‐related cancer risk stratification.

Effects of physical activity type and sedentary time on metabolically healthy obesity and metabolically unhealthy normal weight Korean men

“…According to a study by Gómez-Zorita et al [8], the prevalence of MHO varies from 6-75% depending on the definitional criteria. Moreover, in another study, the prevalence of MUNW was 16-26% [22]. This is because several organizations publish diagnostic criteria for metabolic health [13,23].…”

Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies

“…It is important to highlight the growing evidence that indicates that subjects with type 2 diabetes are at higher risk for some common tumors, including cancers of the prostate, colon, breast, endometrium, pancreas, and liver [ 197 ]. Increased insulin levels may trigger the cancer associations of several additional risk factors [ 198 ], comprising high waist circumference, visceral fat, body mass index, sedentary lifestyle, and an inadequate food intake [ 199 ], among others.…”

Gut microbiota and its derived SCFAs regulate the HPGA to reverse obesity-induced precocious puberty in female rats

“…However, children with obesity, the incidence of metabolic diseases such as hyperinsulinemia, dyslipidemia, disturbances of sex hormones, which are significantly related to childhood obesity, are also increasing. The risk of cancer in adulthood is also significantly increased by childhood obesity (5,6). In recent years, the incidence of precocious puberty in children with obesity has gradually increased.…”